Functional analysis of splicing mutations in exon 7 of NF1 gene

[1]  C. Lázaro,et al.  NF1 mutation rather than individual genetic variability is the main determinant of the NF1‐transcriptional profile of mutations affecting splicing , 2006, Human mutation.

[2]  D. Baralle,et al.  NF1 mRNA biogenesis: Effect of the genomic milieu in splicing regulation of the NF1 exon 37 region , 2006, FEBS letters.

[3]  F. Clark,et al.  Understanding alternative splicing: towards a cellular code , 2005, Nature Reviews Molecular Cell Biology.

[4]  A. Krainer,et al.  Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1 , 2004, Human mutation.

[5]  Gene W. Yeo,et al.  Systematic Identification and Analysis of Exonic Splicing Silencers , 2004, Cell.

[6]  B. Dallapiccola,et al.  Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1 , 2004, Human mutation.

[7]  R. Tenconi,et al.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2 , 2004, Journal of Medical Genetics.

[8]  D. Cooper,et al.  Evaluation of genotype-phenotype correlations in neurofibromatosis type 1 , 2003, Journal of medical genetics.

[9]  F. Natacci,et al.  NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient , 2003, Human Genetics.

[10]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[11]  X. Estivill,et al.  Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients , 2003, Journal of medical genetics.

[12]  Teresa Casals,et al.  New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12. , 2003, Human molecular genetics.

[13]  Rita Mingarelli,et al.  NF1 gene analysis based on DHPLC , 2003, Human mutation.

[14]  J. Vandesompele,et al.  Quantification of NF1 transcripts reveals novel highly expressed splice variants , 2002, FEBS letters.

[15]  B. Dallapiccola,et al.  Ten novel mutations in the human neurofibromatosis type 1 (NF1) gene in Italian patients , 2002, Human mutation.

[16]  W. Vogel,et al.  The N-terminal splice product NF1-10a-2 of the NF1 gene codes for a transmembrane segment. , 2002, Biochemical and biophysical research communications.

[17]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[18]  Jo Vandesompele,et al.  Quantification of splice variants using real-time PCR , 2001, Nucleic Acids Res..

[19]  P. Stadler,et al.  Three different premature stop codons lead to skipping of exon 7 in neurofibromatosis type I patients , 2000, Human mutation.

[20]  G Mortier,et al.  Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.

[21]  X. Estivill,et al.  Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. , 2000, Nucleic acids research.

[22]  K. Wimmer,et al.  Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients , 2000, Human Genetics.

[23]  P. Nürnberg,et al.  Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. , 2000, American journal of human genetics.

[24]  V. Park,et al.  Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene , 1998, Human Genetics.

[25]  P. Nürnberg,et al.  Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. , 1998, American journal of human genetics.

[26]  G. Mortier,et al.  Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene , 1997, Human Genetics.

[27]  G. Vassal,et al.  Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene. , 1995, Human molecular genetics.

[28]  D. Gutmann,et al.  Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  M. Wigler,et al.  A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity , 1993, Molecular and cellular biology.

[30]  T. Yoshimoto,et al.  Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. , 1991, Biochemical and biophysical research communications.

[31]  M. Boguski,et al.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. , 1991, Genomics.

[32]  P. O'Connell,et al.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus , 1990, Cell.

[33]  B. Brownstein,et al.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.

[34]  P. O'Connell,et al.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.